APA (7th ed.) Citation

Sagar, M., Bertilsson, L., Stridsberg, M., Kjellin, A., Mårdh, S., & Seensalu, R. (2000). Omeprazole and CYP2C19 polymorphism: Effects of long-term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders. Alimentary Pharmacology & Therapeutics, 14(11), 1495. https://doi.org/10.1046/j.1365-2036.2000.00835.x

Chicago Style (17th ed.) Citation

Sagar, M., L. Bertilsson, M. Stridsberg, A. Kjellin, S. Mårdh, and R. Seensalu. "Omeprazole and CYP2C19 Polymorphism: Effects of Long-term Treatment on Gastrin, Pepsinogen I, and Chromogranin A in Patients with Acid Related Disorders." Alimentary Pharmacology & Therapeutics 14, no. 11 (2000): 1495. https://doi.org/10.1046/j.1365-2036.2000.00835.x.

MLA (9th ed.) Citation

Sagar, M., et al. "Omeprazole and CYP2C19 Polymorphism: Effects of Long-term Treatment on Gastrin, Pepsinogen I, and Chromogranin A in Patients with Acid Related Disorders." Alimentary Pharmacology & Therapeutics, vol. 14, no. 11, 2000, p. 1495, https://doi.org/10.1046/j.1365-2036.2000.00835.x.